Further studies on the roles of TSPX and TSPY in hepatocarcinogenesis could shed critical insights on the HBV-mediated pathologic process(es), and could lead to developments of genderized strategies for the prevention, diagnosis and treatments of HBV-associated liver cancer. Here, TSPYL2 is linked to liver cancer.